Stock analysts at Bank of America Corporation assumed coverage on shares of LHC Group (NASDAQ:LHCG) in a research report issued to clients and investors on Monday, The Fly reports. The firm set a “buy” rating on the health services provider’s stock.

A number of other analysts also recently commented on the company. Royal Bank Of Canada restated a “buy” rating on shares of LHC Group in a research note on Tuesday, June 13th. Jefferies Group LLC restated a “buy” rating and issued a $65.00 target price on shares of LHC Group in a research note on Friday, June 9th. Benchmark Co. upped their target price on LHC Group from $63.00 to $72.00 and gave the stock a “buy” rating in a research note on Thursday, June 8th. Stephens set a $69.00 target price on LHC Group and gave the stock a “buy” rating in a research note on Saturday, May 6th. Finally, BidaskClub downgraded LHC Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 12th. Ten analysts have rated the stock with a buy rating, The company presently has an average rating of “Buy” and a consensus price target of $65.75.

LHC Group (LHCG) opened at 64.31 on Monday. The company has a market cap of $1.18 billion, a P/E ratio of 28.46 and a beta of 0.77. LHC Group has a 1-year low of $32.04 and a 1-year high of $69.35. The stock has a 50 day moving average price of $63.27 and a 200 day moving average price of $57.46.

LHC Group (NASDAQ:LHCG) last posted its quarterly earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.54 by $0.09. The business had revenue of $260.20 million for the quarter, compared to the consensus estimate of $254.10 million. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The company’s quarterly revenue was up 15.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.52 EPS. On average, equities research analysts anticipate that LHC Group will post $2.39 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This story was reported by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at https://www.americanbankingnews.com/2017/08/21/lhc-group-lhcg-now-covered-by-analysts-at-bank-of-america-corporation.html.

In other LHC Group news, Director Coliseum Capital Management, L sold 107,463 shares of the firm’s stock in a transaction on Tuesday, May 30th. The stock was sold at an average price of $60.63, for a total transaction of $6,515,481.69. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Donald Dwayne Stelly sold 3,181 shares of the firm’s stock in a transaction on Thursday, June 8th. The stock was sold at an average price of $64.97, for a total value of $206,669.57. Following the sale, the chief operating officer now directly owns 114,235 shares of the company’s stock, valued at approximately $7,421,847.95. The disclosure for this sale can be found here. In the last ninety days, insiders sold 546,207 shares of company stock valued at $33,813,733. Insiders own 14.80% of the company’s stock.

A number of large investors have recently bought and sold shares of LHCG. Federated Investors Inc. PA boosted its stake in LHC Group by 4.2% in the second quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock valued at $110,000 after buying an additional 66 shares during the period. Acrospire Investment Management LLC boosted its stake in LHC Group by 30.8% in the second quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock valued at $115,000 after buying an additional 400 shares during the period. Cubist Systematic Strategies LLC boosted its stake in LHC Group by 758.0% in the second quarter. Cubist Systematic Strategies LLC now owns 1,716 shares of the health services provider’s stock valued at $116,000 after buying an additional 1,516 shares during the period. Invictus RG acquired a new stake in LHC Group during the first quarter valued at about $125,000. Finally, US Bancorp DE boosted its stake in LHC Group by 25.1% in the first quarter. US Bancorp DE now owns 2,683 shares of the health services provider’s stock valued at $145,000 after buying an additional 539 shares during the period. 84.95% of the stock is owned by institutional investors.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

The Fly

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.